e constitutional rights issue as in U.S. v. Connolly. 6 documents attached I Read full article » FDA Slams Theranos Execs"Unprecedented' Doc Bid A U.S. Food and Drug Administration attorney on Monday criticized demands by former Theranos CEO Elizabeth Holmes and another executive for internal documents to help them prepare the

onflict because Innate had no business before U.S. regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have ben

0 Forv,ard View web crston P Milken Institute March 2016 Francis Collins, Director, National Institutes of Health; Robert Califf, Commissioner, U.S. Food and Drug Administration; Tom Frieden, Director, U.S. Centers for Disease Control and Prevention; Michael Milken, Chairman, Milken Institute The inaugural Milken Institute